Home Page ελληνικά|
Company  |  News - Publications  |  Offices  |  Conferences  |  Events  |  Newsletter  |  Career  |  Register
 
Services
Credit Risk Services
Marketing and Sales Solutions
Management Consultants
People and Employment Solutions
Contact Center
Servicing & Receivables Management
PHARMACEUTICAL WHOLESALERS
Print    Send Email
 
CATEGORY: OTHER SECTORS
EDITION: 12
DATE: June, 2020
COUNTRY: Greece
 
   
LANGUAGES:  Greek Available Price 731,60 € Buy Now!
  English Not Available
  Bulgarian Not Available
  Romanian Not Available
  Serbian Not Available

Summary
1. Introduction - General Characteristics of the Sector
1.1 Overview of Economic Developments
1.2 Introduction
1.3 Institutional Framework of the Sector of Pharmaceutical Wholesalers
1.4 Distribution Network of Pharmaceutical Wholesalers
Appendix to Chapter 1

2. The Demand for Medicines
2.1 Factors that Shape the Demand for Medicines
2.2 Pharmaceutical and Health Expenditure
2.3 The Infrastructure of the Health System in Greece
2.4 Producer and Consumer Price Index for Pharmaceutical Products
Appendix to Chapter 2

3. The Supply of the Sector
3.1 Structure and Breakdown of the Sector
3.2 Advertising Expenditure of Pharmaceutical Products
3.3 Presentation of Sector Companies
3.4 Total Turover of Sector Companies
3.5 Financial Analysis of Sector Companies
-Profitability
-Performance
-Liquidity
-Financial Structure
-Activity
-Consolidated Balance Sheet Analysis
Comparison of the Financial Ratios of Companies with the Sector - Benchmarking
3.6 Ranking of Sector Companies based on Profitability
3.7 Presentation of Sector Cooperatives
3.8 Total Turnover of Sector Cooperatives
3.9 Financial Analysis of Sector Cooperatives
-Profitability
-Performance
-Liquidity
-Financial Structure
-Activity
-Consolidated Balance Sheet Analysis
Comparison of the Financial Ratios of Companies with the Sector - Benchmarking
3.10 Ranking of Sector Cooperatives based on Profitability
3.11 The Sector's Creditworthiness Over Time
3.11.1 Creditworthiness of Assessed Businesses
3.11.2 Creditworthiness of the Pharmaceuticals-Cosmetics-Detergents Commercial Sector
3.12 The Sector's Trading Conduct Over Time
3.12.1 Trading Conduct of Assessed Businesses
3.12.2 Trading Conduct in the Wider Sector of Pharmaceutical Wholesalers
3.12.3 Trading Conduct of the Pharmaceuticals-Cosmetics-Detergents Commercial Sector
Appendix to Chapter 3

4. The Market of Pharmaceutical Warehouses
4.1 Imports - Exports of Pharmaceutical Products Over Time
4.1.1 Analysis of Imports per Product Group - Principal Countries of Origin
4.1.2 Analysis of Exports per Product Group - Principal Countries of Destination
4.1.3 Index of Competitiveness for Medicines - Trade Balance

4.2 The Domestic Market of Pharmaceutical Wholesalers
Total Market Shares of Pharmaceutical Wholesalers - Concentration Ratio
Appendix to Chapter 4

5. The International and European Market
5.1 The Sector of Pharmaceutical Wholesalers in European Countries
5.2 The International and European Market of Medicines
5.3 Key Data on the Health Industry in OECD Member States

6. Conclusions and Prospects
6.1 Latest Business News in the Sector of Pharmaceutical Warehouses
6.2 Analysis of Competitive Environment - SWOT Analysis
 -General
 -Analysis of Competitive Environment
 -Threat of New Entrants
 -Threat of Substitute Products - Services
 -Bargaining Power of Suppliers
 -Bargaining Power of Customers
 -Competitive Rivalry within the Industry
 -SWOT Analysis
6.3 Prospects
Appendix Ι: Memorandum of Understanding on Specific Economic Policy Conditionality (Health Sector)
Modernization of the healthcare system
Monitoring of pharmaceutical expenditure
Emergency measures for achieving the general objectives
Medicines pricing
Prescribing and monitoring
Increase in the use of generic medicines
Review of medical services by suppliers affiliated with EOPYY
Appendix II:
Α' Balance Sheets of Sector Companies
Β' Balance Sheets of Cooperatives
Appendix III: List of Sector Studies carried out by the Department of Economic Research, ICAP Group SA
 -Benchmarking of Sector Companies
 -Benchmarking of Sector Cooperatives

Tables

App1.1 Legislative framework of the pharmaceutical wholesale sector
App1.2 Legislative framework of the pharmaceutical wholesale sector
Table 2.1 The 65+ age group as a share (%) of the country's total population
Table 2.2 Pharmaceutical and Health Expenditure (2005-2012)
Table 2.3 Producer Price Index in the Manufacturing Industry (2001-2012)
Table 2.4 Consumer Price Index for Medicines (2001-2012)
App2.1 Estimated population in Greece by sex and age group (2010-2012)
App2.2 Population projections of Greece by age (2020-2050)
App2.3 Average monthly health and pharmaceutical expenditure by classes of total monthly value of purchases (2010)
App2.4 Average monthly household expenditure on health, by region category (2010)
Table 3.1 Presentation of sector Companies
Table 3.2 Total turnover of sector companies (2008-2012)
Table 3.3 Profitability ratios of sector companies (2008 - 2012)
Table 3.4 Performance ratios of sector companies (2008 - 2012)
Table 3.5 Liquidity ratios of sector companies (2008 - 2012)
Table 3.6 Financial structure ratios of sector companies (2008 - 2012)
Table 3.7 Activity ratios of sector companies (2008 - 2012)
Table 3.8 Consolidated balance sheet of sector companies (2011 - 2012)
Table 3.9 Consolidated balance sheet of profitable sector companies (2011 - 2012)
Table 3.10 Consolidated balance sheet of loss-making sector companies (2011 - 2012)
Table 3.11 Financial ratios of STROUMSAS, I., PHARMACEUTICALS S.A. and comparison with the sector (2010-2012)
Table 3.12 Financial ratios of PAFARM PAPAZOGLOU BROS S.A. and comparison with the sector (2010-2012)
Table 3.13 Financial ratios of DYNAMIC PHARMA S.A. and comparison with the sector (2010-2012)
Table 3.14 Financial ratios of VITAFARM S.A. and comparison with the sector (2010-2012)
Table 3.15 Financial ratios of PHARMASERVICE S.A. and comparison with the sector (2010-2012)
Table 3.16 Financial ratios of PHARMALUX LTD and comparison with the sector (2010-2012)
Table 3.17 Financial ratios of ALFA PHARM S.A. and comparison with the sector (2010-2012)
Table 3.18 Financial ratios of PROFARM S.A. and comparison with the sector (2010-2012)
Table 3.19 Number of companies that show improvement and deterioration of profitability and return on equity ratios (2012/11)
Table 3.20 Ranking of sector companies based on gross profits (2011-2012)
Table 3.21 Ranking of sector companies based on profit before income tax (2011-2012)
Table 3.22 Ranking of sector companies based on EBITDA profits (2011-2012)
Table 3.23 Presentation of Sector Cooperatives
Table 3.24 Total turnover of sector cooperatives (2008-2012)
Table 3.25 Total turnover of groups of sector cooperatives (2008-2012)
Table 3.26 Profitability ratios of sector cooperatives (2008 - 2012)
Table 3.27 Performance ratios of sector cooperatives (2008 - 2012)
Table 3.28 Liquidity ratios of sector cooperatives (2008 - 2012)
Table 3.29 Financial structure ratios of sector cooperatives (2008 - 2012)
Table 3.30 Activity ratios of sector cooperatives (2008 - 2012)
Table 3.31 Consolidated balance sheet of sector cooperatives (2011 - 2012)
Table 3.32 Consolidated balance sheet of profitable sector cooperatives (2011 - 2012)
Table 3.33 Consolidated balance sheet of loss-making sector cooperatives (2011 - 2012)
Table 3.34 Financial ratios of PHARMACISTS' SUPPLYING COOP. OF ATTIKA L.L.C. GROUP OF COMPANIES and comparison with the sector (2010-2012)
Table 3.35 Financial ratios of THESSALONIKI PHARMACIST SUPPLYING COOP. L.L.C. and comparison with the sector (2009-2011)
Table 3.36 Financial ratios of PEIFASYN PHARMACEUTICAL COOP. OF PIRAEUS L.L.C. and comparison with the sector (2010-2012)
Table 3.37 Financial ratios of SY.F.A.K. L.L.C. and comparison with the sector (2010-2012)
Table 3.38 Financial ratios of PHARMACEUTICAL COOP. OF SOUTH PELOPONNISSOS "SY.FA.NO.P.PE." and comparison with the sector (2010-2012)
Table 3.39 Financial ratios of PROMITHEFTIKOS PARAGOGIKOS SYNETAIRISMOS FARMAKOPOION IMATHIAS PELLIS LLC and comparison with the sector (2010-2012)
Table 3.40 Financial ratios of PHARMACEUTICAL COOPERATIVE OF EVROS PREFECTURE and comparison with the sector (2010-2012)
Table 3.41 Financial ratios of DYTIKI MAKEDONIA PHARMACIST COOP. L.L.C. and comparison with the sector (2010-2012)
Table 3.42 Financial ratios of SEPHAR S.P.E. and comparison with the sector (2010-2012)
Table 3.43 Financial ratios of PROMITHEFTIKOS PHARMACEUTICAL COOP. OF SERRES SYN.PE. and comparison with the sector (2010-2012)
Table 3.44 Number of cooperatives that show improvement and deterioration of profitability and return on equity ratios (2012/11)
Table 3.45 Ranking of cooperatives based on gross profits (2011-2012)
Table 3.46 Ranking of cooperatives based on profit before income tax (2011-2012)
Table 3.47 Ranking of cooperatives based on EBITDA profits (2011-2012)
Table 3.48 Creditworthiness of Assessed Businesses (2012-2011)
Table 3.49 Creditworthiness of the Pharmaceuticals-Cosmetics-Detergents Commercial Sector
Table 3.50 Trading Conduct of Assessed Businesses (2012-2011)
Table 3.51 Trading Conduct in the Wider Sector of Pharmaceutical Wholesalers (2012-2011)
Table 3.52 Trading Conduct of the Pharmaceuticals-Cosmetics-Detergents Commercial Sector (2012-2011)
App3.1 Overall number of pharmacies by prefecture over time (2005-2012)
App3.2 Breakdown of the advertising expenditure of pharmaceutical products per medium (2006-2012)
App3.3 Advertising expenditure of pharmaceutical products per brand (2011-2012)
Table 4.1 Trade balance of medicines (2008-2012)
Table 4.3 Market Size of Pharmaceutical Wholesalers (2007-2012)
Table 4.2 Parallel Exports of Medicines
Table 4.4 Shares of Pharmaceutical Wholesalers (2012)
Table 4.5 Market Shares of Groups (2012)
Table 4.6 Concentration Ratio
Table 4.7 Market Shares of Companies (2012)
Table 4.8 Market Shares of Cooperatives (2012)
App4.1 Description of Intrastat 8-digit Combined Nomenclature of External Trade Codes
App4.2 Imports of pharmaceutical products in value (2008-2012)
App4.3 Breakdown of imports of pharmaceutical products by origin (2008-2012)
App4.4 Exports of pharmaceutical products in value (2008-2012)
App4.5 Breakdown of exports of pharmaceutical products by destination (2008-2012)
Table 5.1 Information on the pharmaceutical wholesale sector per European country (2011)
Table 5.2 The pharmaceutical industry in Europe (2008 - 2011)
App5.1 The top selling medicines (2012)
App5.2 Overall pharmaceutical expenditure as a share (%) in the gross domestic product in OECD member-states (1998-2011)
App5.3 Overall pharmaceutical expenditure as a share (%) in the overall health expenditure in OECD member-states (1998-2011)

Graphs

Graph 2.1 Pharmaceutical Expenditure over time (2005-2012)
Graph 3.1 Advertising expenditure of pharmaceutical products (2012)
Graph 4.1 Imports of pharmaceutical products in value over time (2008-2012)
Graph 4.2 Exports of pharmaceutical products in value over time (2008-2012)
Graph 4.3 Trade balance and Balassa index of competitiveness in the sector of medicines (2008-2012)
Graph 4.4 The Domestic Market of Medicines Over Time (2007-2012)
Graph 4.5 Breakdown of the Total Pharmaceutical Wholesale Market (2012)
Graph 5.1 Overall sales of Medicines globally over time (2008-2016)

Search
 

In-depth knowledge of the business sectors that you are interested in!

Customer Care
Tel: +30 210 7200 050
Email: customercare@icap.gr
 
Subject Access Request (SAR)  |  Cookies Policy  |  Privacy Notice  |  No Transmit data  |  Brochures  |  Site Map  |  Links
Designed & developed by EXUS | powered by eCentric Copyright © 2008-2020 ICAP. All rights reserved